Verastem (VSTM) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 15.31% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -76.51% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -303.06% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.06% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.72% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,150.63% |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 48.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.92% |
| Dec 31, 2025 | 840.10% |
| Sep 30, 2025 | -295.69% |
| Jun 30, 2025 | -2,624.92% |
| Mar 31, 2025 | -826.56% |
| Dec 31, 2024 | 0.85% |
| Sep 30, 2024 | -70.90% |
| Jun 30, 2024 | 11.28% |
| Mar 31, 2024 | 1.29% |
| Dec 31, 2023 | -19.49% |
| Sep 30, 2023 | 23.58% |
| Jun 30, 2023 | 45.87% |
| Mar 31, 2023 | 91.70% |
| Dec 31, 2022 | 98.59% |
| Sep 30, 2022 | -1,227.60% |
| Jun 30, 2022 | -111.21% |
| Mar 31, 2022 | -1,995.51% |
| Dec 31, 2021 | -13,243.62% |
| Sep 30, 2021 | -123.51% |
| Jun 30, 2021 | -39.09% |
| Mar 31, 2021 | -485.95% |
| Dec 31, 2020 | -102.68% |
| Sep 30, 2020 | 252.80% |
| Jun 30, 2020 | -54.20% |
| Mar 31, 2020 | 64.89% |
| Dec 31, 2019 | 29.57% |
| Sep 30, 2019 | 79.31% |
| Jun 30, 2019 | 79.06% |
| Mar 31, 2019 | 83.74% |
| Dec 31, 2018 | 84.25% |
| Sep 30, 2018 | 88.10% |
| Jun 30, 2018 | 71.46% |
| Mar 31, 2018 | 96.05% |